EMCDDA Home
  • EN
Search

Figure TDI-3. Trend in estimated number of all clients entering treatment by selected primary drugs, 2006–2011

Part (ii) Numbers of clients by primary drug

 
 
Related links:
See also ‘General notes for interpreting data’ on the Explanatory notes and help page
See also Table TDI-102 and Figure TDI-1 part (ii)

Notes:

Countries included: Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Luxembourg, Latvia, Lithuania, Hungary, Netherlands, Austria, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, United Kingdom, Croatia and Turkey.

Data for Latvia, Lithuania and Portugal are for clients entering treatment for the first time in their life.

Missing data were interpolated by assigning for the respective country the value for most recent year available. Altogether, 2.7% of the data points and 7.4% of the number of clients were interpolated.

Sources:

Reitox national reports 2012 & TDI

Primary Drug 2006 2007 2008 2009 2010 2011
Heroin 185300 183422 193897 187486 171026 169545
Cocaine 61390 63897 73660 65509 60453 58821
Cannabis 81788 75711 88740 99500 104329 105143
Other stimulants 22425 20938 20830 20200 22813 25453
Other drugs 42011 30845 35190 36956 36175 35981
Not known / missing 40845 14393 23143 23372 34094 34551

tdifig3b

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 08 May 2013